2-chloro-1-fluoro-4-isothiocyanatobenzene

We are 2-chloro-1-fluoro-4-isothiocyanatobenzene CAS:137724-66-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-chloro-1-fluoro-4-isothiocyanatobenzene
CAS.NO:137724-66-4
Synonyms:2-chloro-1-fluoro-4-isothiocyanatobenzene
3-Chloro-4-fluorophenyl isothiocyanate
3-chloro-4-fluorobenzenisothiocyanate
2-chloro-1-fluoro-4-isothiocyanato-benzene
 
Physical and Chemical Properties:
Density 1.31g/cm3
Boiling Point 115-117 °C (11 mmHg)
Molecular Formula C7H3ClFNS
Molecular Weight 187.62200
Flash Point 130-132°C/15mm
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2-chloro-1-fluoro-4-isothiocyanatobenzene


Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.2-Methoxyphenylboronic acid CAS:5720-06-9 There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.141-90-2 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.2-bromo-3-cloro-5-nitropiridina CAS:22353-41-9 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
Azathioprine View Details
Octabenzone View Details
DL-Ornithine Monohydrochloride View Details
t-Butyl 4-bromobutanoate manufacturer N-Phenylglycine manufacturer trans-4-Methylcyclohexyl amine manufacturer 2,6-Dichloropurine manufacturer 1-Boc-L-proline Methyl Ester manufacturer